Sonoma Pharmaceuticals
SNOA
18 hedge funds and large institutions have $1.41M invested in Sonoma Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 18 → 18 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
61% less capital invested
Capital invested by funds: $3.58M → $1.41M (-$2.17M)
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$76.9K |
| 2 |
Barclays
London,
United Kingdom
|
+$59.2K |
| 3 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
+$56.2K |
| 4 |
U
UBS
Zurich,
Switzerland
|
+$11.8K |
| 5 |
VIA
Vantage Investment Advisors
State College,
Pennsylvania
|
+$8.88K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
Bard Associates
Chicago,
Illinois
|
-$586K |
| 2 |
SC
Sophrosyne Capital
New York
|
-$522K |
| 3 |
Morgan Stanley
New York
|
-$482K |
| 4 |
NL
NWAM LLC
Mercer Island,
Washington
|
-$107K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$71K |
SNOA Hedge Fund Activity: Q2 2014 in Review
18 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q2 2014, worth a combined $1.41M — down 61% from $3.58M a quarter earlier.
Fund positioning in SNOA was balanced in Q2 2014: 4 funds opened new positions, 4 closed out, 1 added to existing stakes and 5 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $76.9K. The largest seller was Bard Associates, cutting an estimated $586K.
- 18 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q2 2014, unchanged from Q1 2014.
- Funds reported $1.41M of Sonoma Pharmaceuticals stock for Q2 2014, down 61% quarter-over-quarter.
- 4 funds opened new Sonoma Pharmaceuticals positions in Q2 2014 and 4 closed out, a net change of 0 holders.
- The largest Sonoma Pharmaceuticals buyer in Q2 2014 was Jane Street, an estimated $76.9K added.
- The largest Sonoma Pharmaceuticals seller in Q2 2014 was Bard Associates, an estimated $586K sold.
Based on aggregated 13F filings for Q2 2014.